Skip to content

Impact of GnRH agonist on cesarean scar diverticulum after vaginal surgery

A new measure of cesarean scar diverticulum surgery and its standardization to promote research

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16008537
Enrollment
Unknown
Registered
2016-05-25
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section scar diverticulum

Interventions

vaginal surgery:nothing
vaginal surgery with GnRH agonist:GnRH agonist

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients younger than 40; 2. The medicine conservative treatment is invalid; 3. Refusing or use birth control pills contraindications; 4. No serious medical problems (important viscera function in the normal range); 5. No uterine fibroids, endometriosis, adenomyosis, and patients with ovarian cysts; 6. No gynaecology or other malignant tumors; 7. Prepare early surgical treatment of the subjects; 8. The subjects are able and willing to comply with research plan; 9. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. patients over the age of 40; 2. refuse to surgery, or surgery have doubts; 3. with severe medical problems (severe liver disease, kidney disease, respiratory diseases, heart disease or uncontrolled diabetes, epilepsy, etc., dysfunction of important organs); 4. the combination of uterine fibroids, endometriosis, adenomyosis, and patients with ovarian cysts; 5. merger or other malignant tumor patients of department of gynaecology; 6. can't cooperate with treatment of psychiatric patients; 7. unwilling or unable to comply with the research plan.

Design outcomes

Primary

MeasureTime frame
Menstrual days;thickness of the remaining muscular layer of CSD;menstrual cycle;CSD length;CSD width;CSD depth;

Secondary

MeasureTime frame
operation time;blood loss of operation;cesarean section factor;

Countries

China

Contacts

Public ContactXipeng Wang

Shanghai First Maternity and Infant Hospital

xipengwang@hotmail.com+86 13817806602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026